FFGRX
Price
$33.87
Change
-$0.76 (-2.19%)
Updated
Jul 13 closing price
Net Assets
1.56B
VEXPX
Price
$132.98
Change
-$1.79 (-1.33%)
Updated
Jul 13 closing price
Net Assets
23.31B
Interact to see
Advertisement

FFGRX vs VEXPX

FFGRX vs VEXPX Comparison Chart in %
View a ticker or compare two or three
VS
FFGRX vs. VEXPX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FFGRX is a Hold and VEXPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXPX has more cash in the bank: 23.3B vs. FFGRX (1.56B). VEXPX pays higher dividends than FFGRX: VEXPX (0.36) vs FFGRX (0.00). FFGRX was incepted earlier than VEXPX: FFGRX (15 years) vs VEXPX (59 years). FFGRX (1.15) is less costly to investors than VEXPX (0.39). VEXPX is a more actively managed with annual turnover of: 51.00 vs. FFGRX (45.00). FFGRX has a lower initial minimum investment than VEXPX: FFGRX (2000) vs VEXPX (3000). FFGRX annual gain was more profitable for investors over the last year : 41.23 vs. VEXPX (17.57). FFGRX return over 5 years is better than : 4.45 vs. VEXPX (-4.91).
FFGRXVEXPXFFGRX / VEXPX
Total Expense Ratio1.130.39290%
Annual Report Gross Expense Ratio1.150.39295%
Fund Existence15 years59 years-
Gain YTD30.77817.385177%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets1.56B23.3B7%
Annual Yield % from dividends0.000.36-
Returns for 1 year41.2317.57235%
Returns for 3 years59.0926.97219%
Returns for 5 years4.45-4.91-91%
Returns for 10 years89.2958.81152%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUERX39.33N/A
N/A
MFS Blended Research Core Equity R1
NBSTX64.77N/A
N/A
Neuberger Quality Equity Tr
UMLGX7.79N/A
N/A
Columbia Select Large Cap Growth Inst
LOFLX16.48N/A
N/A
Lord Abbett Focused Large Cap Value F3
RNPBX68.69-0.93
-1.34%
American Funds New Perspective R-2